PharmAthene, Inc. (PIP)
-NYSE MKT 1.66 
0.02(1.22%) 1:23PM EDT - Nasdaq Real Time Price
| Prev Close: | 1.64 |
|---|
| Open: | 1.65 |
|---|
| Bid: | 1.65 x 1000 |
|---|
| Ask: | 1.66 x 1000 |
|---|
| 1y Target Est: | 7.25 |
|---|
| Beta: | 1.94 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 1.65 - 1.71 |
|---|
| 52wk Range: | 0.98 - 2.05 |
|---|
| Volume: | 71,390 |
|---|
| Avg Vol (3m): | 400,713 |
|---|
| Market Cap: | 82.10M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.09 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- July Options Now Available For PharmAthene (PIP)at TheStreet(Mon, May 20)
- PHARMATHENE, INC FinancialsEDGAR Online Financials(Tue, May 14)
- Biodefense: Live By Government Contracts, Die By Government Contractsat Seeking Alpha(Sun, May 12)
- PharmAthene Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed, May 8)
- PharmAthene, Inc. Earnings Call scheduled for 4:30 pm ET todayCCBN(Wed, May 8)
- PharmAthene Reports First Quarter 2013 Financial And Operational ResultsPR Newswire(Wed, May 8)
- PHARMATHENE, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Wed, May 8)
- Q1 2013 PharmAthene, Inc. Earnings Release - After Market CloseCCBN(Wed, May 8)
- PharmAthene To Host First Quarter 2013 Conference Call And Webcast On Wednesday, May 8, 2013PR Newswire(Mon, May 6)
- Trucks Oust Buffaloes as Aquino $6.5 Billion Adds Roads: Freightat Bloomberg(Wed, Apr 24)
- PharmAthene says Army completed recombinant bioscavenger testingat theflyonthewall.com(Wed, Apr 17)
- New Data Show PharmAthene's Recombinant Bioscavenger Binds To A Broad Spectrum Of Chemical Nerve AgentsPR Newswire(Wed, Apr 17)
- PHARMATHENE, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements aEDGAR Online(Mon, Mar 25)
- PharmAthene Inc. Stock Downgraded (PIP)at TheStreet(Fri, Mar 15)
- New Star Analyst Rankings for PharmAthene, Inc Common StockStarMine(Thu, Mar 14)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 3.18 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.03 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.06 |
|---|
| Mean Recommendation*: | 2.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
PharmAthene, Inc., a biodefense company, engages in the development and commercialization of medical countermeasures against biological and chemical threats in the United States.
View More